InvestorsHub Logo
icon url

chipboarder

03/15/24 11:45 AM

#232151 RE: iateclube #232150

I bought a small position in MOVE not because of the EVIE ring but because of their unique approach of using radio frequency instead of infrared to measure various parameters. I’m more interested in oxygen, blood pressure and glucose for starters..Down the road I would like them to expand into male health…why ignore half the potential market? Targets such as blood alcohol (or TCH), testosterone, PSA and the enzymes associated with heart attack. LiquidMetal could be in the middle of all this because it’s transparent to RF energy.

I see MOVE as an acquisition target but I would hate to see someone pick the up for $3-$4 when the potential could be so much larger